Transmissibility and infection control implications of Burkholderia cepacia in cystic fibrosis

Canadian Journal of Infectious Diseases

Volumn 9, Issue 3, 1998, Pages 177-182

  Fung, Scott K ^a   Dick, H ^a   Devlin, H ^a   Tullis, E ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Burkholderia cepacia; Cystic fibrosis; Infection control; Pseudomonas cepacia; Pulmonary infection; Transmissibility

Indexed keywords

VIRULENCE FACTOR;

BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; BURKHOLDERIA CEPACIA; CROSS INFECTION; CYSTIC FIBROSIS; DETERIORATION; DISEASE TRANSMISSION; HOSPITALIZATION; HUMAN; INFECTION CONTROL; MULTIDRUG RESISTANCE; REVIEW; RISK FACTOR;

EID: 0031831609     PISSN: 11802332     EISSN: None     Source Type: Journal    
DOI: 10.1155/1998/269157     Document Type: Review

References (31)

1. Davis P. Cystic fibrosis: New perceptions, new strategies. Hosp Practice 1992;27:79-118.
2. Govan J, Nelson J. Microbiology of cystic fibrosis lung infections: Themes and issues. J Royal Soc Med 1993;86:11-6.
3. Niroumand M, Tullis E. A case-by-case approach to older cystic fibrosis patients. Can J Diagnosis 1997;14:109-17.
4. Stableforth D, Smith D. Pseudomonas cepacia in cystic fibrosis. Thorax 1994;49:629-30. (Edit)
5. Dick H, Borczyk A, Kiani G, Chang D, Devlin H. Rapid identification of Burkholderia cepacia from cystic fibrosis patients. Proceedings of the 9th Annual North American CF Conference. Dallas, Texas, October 12-15, 1995.
6. Tablan O, Carson L, Cusick L, Bland L, Martone W, Jarvis W. Laboratory proficiency test results on use of selective media for isolating Pseudomonas cepacia from simulated sputum specimens from patients with cystic fibrosis. J Clin Microbiol 1987;25:485-7.
7. Mahenthiralingam E, Simpson D, Speert D. Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis. J Clin Microbiol 1997;35:808-16.
8. Goldstein R, Sun L, Jiang R, Sajjan U, Forstner F, Campanelli C. Structurally variant classes of pilus appendage fibers coexpressed from Burkholderia (Pseudomonas) cepacia. J Bacteriol 1995;177:1039-52.
9. Speert D, Bond M, Woodman R, Curnutte J. Infection with Pseudomonas cepacia in chronic granulomatous disease: role of nonoxidative killing by neutrophils in host defense. J Infect Dis 1994;170:1524-31.
10. Burns J, Jonas M, Chi E, Clark D, Berger A, Griffith A. Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia. Infect Immun 1996;64:4054-9.
11. Sanders, C. β-Lactamases of Gram-negative bacteria: new challenges for new drugs. Clin Infect Dis 1992;14:1089-99.
12. Taylor R, Gaya H, Hodson M. Pseudomonas cepacia: pulmonary infection in patients with cystic fibrosis. Respir Med 1993;87:187-92.
13. Snell G, de Hoyos A, Krajden M, Winton T, Maurer J. Pseudomonas cepacia in lung transplant recipients with cystic fibrosis. Chest 1993;103:466-71.
14. Mahenthiralingam E, Campbell M, Speert D. Burkholderi cepacia in cystic fibrosis. N Engl J Med 1995;332:819-20. (Comm)
15. Maslow J, Mulligan M, Arbeit R. Molecular epidemiology: application of contemporary techniques to the typing of microorganisms. Clin Infect Dis 1993;17:153-64.
16. LiPuma J, Dasen S, Nielson D, Stem R, Stull T. Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet 1990;336:1094-6.
17. Govan J, Brown P, Maddison J, et al. Evidence for transmission of Pseudonionas cepacia by social contact in cystic fibrosis. Lancet 1993;342:15-9.
18. Mahenthiralingam E, Campbell M, Henry D, Speert D. Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis of randomly amplified polymorphic DNA fingerprinting. J Clin Microbiol 1996;34:2914-20.
19. Steinbach S, Sun L, Jiang R, et al. Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis. N Engl J Med 1994;331:981-7.
20. Goering R. Molecular epidemiology of nosocomial infection: analysis of chromosomal restriction fragment patterns by pulsed-field gel electrophoresis. Infect Control Hosp Epidemiol 1993;14:595-9.
21. Humphreys H, Peckham D, Patel P, Knox A. Airborne dissemination of Burkholderia (Pseudomonas) cepacia from adult patients with cystic fibrosis. Thorax 1994;49:1157-9.
22. Pegues D, Carson L, Tablan O, et al. The Summer Camp Study Group. Acquisition of Pseudomonas cepacia at summer camps for patients with cystic fibrosis. J Pediatr 1994;124:694-702.
23. Pseudomonas cepacia at summer camps for persons with cystic fibrosis. Morb Mortal Wkly Rep 1993;42:456-9.
24. + Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nature Med 1995;1:661-6.
25. Pegues D, Schidlow D, Tablan O, Carson L, Clark N, Jarvis W. Possible nosocomial transmission of Pseudomonas cepacia in patients with cystic fibrosis. Arch Pediatr Adolesc Med 1994;148:805-12.
26. Doring G, Jansen S, Noll H, et al. Distribution and transmission of Pseudonionas aeruginosa and Burkholderia cepacia in a hospital ward. Pediatr Pulmonol 1996;21:90-100.
27. Burdge D, Nakielna E, Noble M. Case-control and vector studies of nosocomial acquisition of Pseudomonas cepacia in adult patients with cystic fibrosis. Infect Control Hosp Epidemiol 1993;14:127-30.
28. Conly J, Klass L, Larson L. Pseudomonas cepacia colonization and infection in intensive care units. Can Med Assoc J 1986;134:363-6.
29. Hamill R, Houston E, Georghiou P, et al. An outbreak of Burkholdria (formerly Pseudomonas) cepacia respiratory tract colonization and infection associated with nebulized albuterol therapy. Ann Intern Med 1995;22:762-6.
30. Whiteford M, Wilkinson J, McColl J, et al. Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak. Thorax 1995;50:1194-8.
31. Wellesley Central Hospital Infection Control Manual 1995. Guidelines for management of cystic fibrosis patients. Toronto: Wellesley Central Hospital, 1995.